Immunogenicity of peptides derived from a fibronectin-binding protein of S. aureus expressed on two different plant viruses

Vaccine

Volumn 17, Issue 15-16, 1999, Pages 1846-1857

  Brennan, F R ^a   Jones, T D ^a   Longstaff, M ^a   Chapman, S ^a   Bellaby, T ^a   Smith, H ^a   Xu, F ^a   Hamilton, W D O ^a   Flock, J I ^b  

^a Axis Genetics plc   (United Kingdom)

^b Pathol Infect Dis   (Sweden)

Author keywords

Chimaeric plant viruses; Fibronectin binding protein; S. aureus

Indexed keywords

COMPLEMENT COMPONENT C1Q; FIBRONECTIN; PEPTIDE;

ANTIBODY SPECIFICITY; ARTICLE; COMPLEMENT ACTIVATION; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; EXTRACELLULAR MATRIX; IMMUNOGENICITY; NONHUMAN; OPPORTUNISTIC INFECTION; PEPTIDE SYNTHESIS; PLANT VIRUS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; STAPHYLOCOCCUS AUREUS;

ADHESINS, BACTERIAL; AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL PROTEINS; BACTERIAL VACCINES; BINDING, COMPETITIVE; CARRIER PROTEINS; COMOVIRUS; COMPLEMENT C1Q; FEMALE; FIBRONECTINS; IMMUNOGLOBULIN G; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PLANT VIRUSES; POTEXVIRUS; PROTEIN BINDING; RATS; STAPHYLOCOCCUS AUREUS; VACCINATION; VACCINES, SYNTHETIC;

EID: 0033537861     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)00485-X     Document Type: Article

References (45)

1. Sheagren J.N. Staphylococcus aureus: the persistent pathogen. N. Engl. J. Med. 310:1984;1368-1373.
2. Shanson D.C. Staphylococcal infections in hospitals. Br. J. Hosp. Med. 35:1990;312.
3. Waldvogel FA. Staphylococcus aureus (including toxic shock syndrome). In: Mandell GL, Douglas RG, Bennett JE, editors. Principles and practice of infectious diseases. New York: John Wiley, 1985. p. 1096.
4. Sutra L., Poutrel B. Virulence factors involved in the pathogenesis of bovine intramammary infections due to Staphylococcus aureus. J. Med. Microbiol. 40:1994;78-89.
5. Noble W.C., Virani Z., Cree R.G.A. Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to S. aureus. FEMS Microbiol. Lett. 93:1992;195-198.
6. Fattom A.I., Naso R. Staphylococcal vaccines: a realistic dream? Ann. Med. 28:1996;43-46.
7. Foster T.J. Potential for vaccination against infections caused by Staphylococcus aureus. Vaccine. 9:1991;221-227.
8. Fattom A.I., Sarwar J., Oritz A., Naso R. A Staphylococcus aureus capsular polysaccharide (CP) vaccine and CP-specific antibodies protect mice against bacterial challenge. Infect. Immun. 64:1996;1659-1665.
9. Fedson D.S., Shapiro E.D., Laforce F.M., Mufson M.A., Musher D.M., Spika J.S., Breiman R.F., Broome C.V. Pneumococcal vaccine after 15 years of use. Another review. Arch. Intern. Med. 154:1994;2531-2535.
10. Flock J.I., Froman G., Jonsson K., Guss B., Signas C., Nilsson B., Raucci G., Hook M., Wadstrom T., Lindberg M. Cloning and expression of the gene for a fibronectin-binding protein of Staphylococcus aureus. EMBO J. 6:1987;2351-2357.
11. Signas C., Raucci G., Jonsson K., Lindgren P.-E., Ananthara-maiiah G.M., Hook M., Lindberg M. Nucleotide sequence of the gene for a fibronectin-binding protein from Staphylococcus aureus: use of this peptide sequence in the synthesis of biologically active peptides. Proc. Natl. Acad. Sci. USA. 86:1989;699-703.
12. Switalski L., Speziale P., Hook M. Isolation and characterization of a putative collagen receptor from Staphylococcus strain Cowan 1. J. Biol. Chem. 264:1989;21080-21086.
13. McDevitt D., Francois P., Vaudaux P., Foster T.J. Molecular characterization of the clumping factor (fibrinogen receptor) of Staphylococcus aureus. Mol. Microbiol. 11:1994;237-248.
14. Liang O., Maccarana M., Flock J.-I., Paulsson M., Preissner K.T., Wadstrom T. Multiple interactions between human vitronectin and Staphylococcus aureus. Biochem. Biophys. Acta. 1225:1993;57-63.
15. Vaudaux P., Pittet D., Heaberli A., Huggler E., Nydegger U.E., Lew D., Waldvogel A. Host factors selectively increase staphylococcal adherence on inserted catheters: role for fibronectin and fibrinogen or fibrin. J. Infect. Dis. 160:1989;865-875.
16. Vaudaux P., Pittet D., Haeberli A., Lerch P.G., Morgenthaler J.-J., Proctor R., Waldvogel F.A., Lew D. Fibronectin is more active than fibrin or fibrinogen in promoting Staphylococcus aureus adherence to inserted intravascular catheters. J. Infect. Dis. 167:1993;633-641.
17. Nelson L, Flock J-I, Hook M, Lindberg M, Muller HP, Wadstrom T. Adhesins in staphylococcal mastitis as vaccine components. In: Burvenich C, Vandeputte-van Messom G, Hill AW, editors. New insights into the pathogenesis of mastitis. Rijksuniversiteit Gent, 1991. p. 111-25.
18. Mamo W., Jonsson P., Flock J.-I., Lindberg M., Muller H.-P., Wadstrom T., Nelson L. Vaccination against Staphylococcus aureus mastitis: immunological response of mice vaccinated with fibronectin-binding protein (FnBP-A) to challenge with S. aureus. Vaccine. 12:1994;988-992.
19. Kuypers J.M., Proctor R.A. Reduced adherence to traumatized rat heart valves by a low fibronectin-binding mutant of Staphylococcus aureus. Infect. Immun. 57:1989;2306-2312.
20. Flock J.-I., Heinz S., Schennings T., Heimdahl A. Reconsideration of the role of fibronectin binding in endocarditis caused by Staphylococcus aureus. Infect. Immun. 64:1996;1876-1878.
21. Jonsson K., Signas C., Muller H.P., Lindberg M. Two different genes encode fibronectin-binding proteins in Staphylococcus aureus: the complete nucleotide sequence and characterisation of the second gene. Eur. J. Biochem. 202:1991;1014-1048.
22. Huff S., Matsuka Y.V., McGavin M.J., Ingham K.C. Interaction of N-terminal fragments of fibronectin with synthetic and recombinant D-motifs from its binding protein on Staphylococcus aureus studies using fluorescence anisotropy. J. Biol. Chem. 269:1994;15563-15570.
23. McGavin M.J., Raucci G., Gurisiddappa S., Hook M. Fibronectin-binding determinants of the Staphylococcus aureus fibronectin receptor. J. Biol. Chem. 266:1991;8343-8347.
24. Sun Q., Smith G.M., Zahradka C., McGavin M.J. Identification of D motif epitopes in Staphylococcus aureus fibronectin-binding protein for the production of antibody inhibitors of fibronectin binding. Infect. Immun. 65:1997;537-543.
25. Luk M.-C.J., Flock J.-I., Wadstrom T. Detection in rabbit sera of blocking antibodies against Staphylococcal fibronectin binding protein by enzyme-linked immunosorbent assay. FEMS Microbiol. Immunol. 47:1989;505-510.
26. Ciborowski P., Flock J.-I., Wadstrom T. Immunological response to a Staphylococcus aureus fibronectin-binding protein. J. Med. Microbiol. 37:1992;376-381.
27. Schennings T., Heimdahl A., Coster K., Flock J.-I. Immunization with fibronectin binding protein from Staphylococcus aureus protects against experimental endocarditis in rats. Microb. Pathogen. 15:1993;227-236.
28. Rozzalska B., Wadstom T. Protective opsonic activity of antibodies fibronectin binding proteins (FnBPs) of Staphylococcus aureus. Scand. J. Immunol. 37:1993;575-580.
29. Mamo W., Jonsson P., Muller H.-P. Opsonization of Staphylococcus aureus with a fibronectin-binding protein antiserum induces protection in mice. Microb. Pathogen. 19:1995;49-55.
30. Usha R., Rohll J., Spall V.E., Shanks M., Maule A.J., Johnson J.E., Lomonossoff G.P. Expression of an animal virus antigenic site on the surface of a plant virus particle. Virology. 197:1993;366-374.
31. Santa Cruz S., Chapman S.N., Roberts A.G., Roberts I.M., Prior D.A.M., Oparka K.J. Assembly and movement of a plant virus carrying a green fluorescent protein overcoat. Proc. Natl. Acad. Sci. USA. 93:1996;6286-6290.
32. McLain L., Porta C., Lomonossoff G.P., Durrani Z., Dimmock N.J. Human immunodeficiency virus type 1 neutralizing antibodies raised to a gp41 peptide expressed on the surface of a plant virus. AIDS Res. Hum. Retro. 11:1995;327-334.
33. Dalsgaard K., Uttenthal A., Jones T.D., Xu F., Merryweather A.M., Hamilton W.D.O., Langeveld J.P., Boshuizen R.S., Kamstrup S., Lomonossoff G.P., Porta C., Vela C., Casal J.I., Meloen R.H., Rodgers P.B. Plant-derived vaccine protects target animals against a viral disease. Nature Biotechnol. 15:1997;248-252.
34. Dessens J.T., Lommonossoff G.P. Cauliflower mosaic virus 35S promoter-controlled DNA copies of cowpea mosaic virus RNAs are infectious on plants. J. Gen. Virol. 74:1993;889-892.
35. Kavanagh T., Goulden M., Santa Cruz S., Chapman S., Barker I., Baulcombe D. Molecular analysis of a resistance-breaking strain of Potato virus X. Virology. 189:1992;609-617.
36. Baulcombe D.C., Flavell R.B., Boulton R.E., Jellis G.J. The sensitivity and specificity of a rapid nucleic acid hybridisation method for the detection of potato virus X in crude sap samples. Plant Pathol. 33:1994;361-370.
37. Eckhardt A., Heiss M.M., Ehret E., Permanetter W., Duchene M., Domdey H., von Specht B.-U. Evaluation of protective mAbs against Pseudomonas aeruginosa outer membrane I by C1q binding assay. Zbl. Bakt. 275:1991;100-111.
38. Kensil C.R., Patel U., Lennick M., Marciani D. Separation and characterisation of saponins with adjuvant activity from Quillaja saponaria Molina cortex. J. Immunol. 146:1991;431-437.
39. Cooper PD. The selective induction of different immune responses by vaccine adjuvants. In: Ada GI, editor. Vaccine design. R.G. Landes Company, 1994. p. 125-58.
40. Haynes J.R., Cunningham J., von Seefried A., Lennick M., Garvin R.T., Shen S. Development of a genetically-engineered candidate polio vaccine employing the self-assembling properties of the tobacco mosaic virus coat protein. Biotechnology. 4:1986;637-640.
41. Fitchen J., Beachy R.N., Hein M.B. Plant virus expressing hybrid coat protein with added murine epitope elicits autoantibody response. Vaccine. 13:1995;1051-1057.
42. Turpen T.H., Reinl S.J., Charoenvit Y., Hoffman S.L., Fallarme V., Grill L.K. Malarial epitopes expressed on the surface of recombinant tobacco mosaic virus. Bio/Technology. 13:1995;53-57.
43. Speziale P., Joh D., Visai L., Bozzini S., House-Pompeo K., Lindberg M., Hook M. A monoclonal antibody enhances ligand binding of fibronectin MSCRAMM (adhesin) from Streptococcus dysgalactiae. J. Biol. Chem. 271:1996;1371-1379.
44. House-Pompeo K., Xu Y., Joh D., Speziale P., Hook M. Conformational change in the fibronectin binding MSCRAMMs are induced by ligand binding. J. Biol. Chem. 271:1996;1379-1384.
45. McGavin, MJ, Gurusiddappa S, Lindgren PE, Lindberg M, Raucci G, Hook A. Fibronectin receptors from streptococcus dysgalactiae and staphylococcus aureus. Involvement of conserved residues in ligand binding. J. Biol. Chem. 1993;268:23946-53.